|
|
| Médicaments En Vente Libre > Etude de marché sectorielle |
| OTC Pharmaceuticals in Australia |
|
|
|
|
€ 160,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Février 2007 |
Taille du document : |
19 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
US Nasal Products 2004
13 pages | Juillet 2004 |
Snapdata's US Nasal Products 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US nasal product market, and co |
240,00 €
|
| |
| |
US Mineral Supplements 2004
12 pages | Novembre 2004 |
Snapdata's US Mineral Supplements 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US mineral supplement mark |
240,00 €
|
| |
| |
UK Smoking Cessation Aids 2004
12 pages | Juillet 2004 |
Snapdata's UK Smoking Cessation Aids 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the UK smoking cessation ai |
240,00 €
|
| |
| |
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players
87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand |
2 443,75 €
|
| |
| |
Chinese Markets for OTC Drugs
220 pages | Février 2002 |
China's demand for OTC drugs has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic trend |
2 835,00 €
|
| |
| |
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players
87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand |
1 520,00 €
|
| |
| |
US Cough Syrup 2004
12 pages | Juillet 2004 |
Snapdata's US Cough Syrup 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US cough syrup market, and covers |
240,00 €
|
| |
| |
US Ear Care Drops 2004
12 pages | Juillet 2004 |
Snapdata's US Ear Care Drops 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US ear care drop market, and co |
240,00 €
|
| |
| |
Poland Contraceptives 2004
12 pages | Juillet 2004 |
Snapdata's Poland Contraceptives 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the Polish contraceptive market |
240,00 €
|
| |
| |
US Analgesics 2004
14 pages | Juillet 2004 |
Snapdata's US Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US analgesic market, and covers non |
240,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC Pharmaceuticals in Australia |
|
|
Datamonitor's OTC Pharmaceuticals in Australia industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual analysis of the key trends and competitive landscape, demographic information, and descriptions of the leading companies.
Scope
* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and leading companies
* Includes a five-year forecast of the industry
* Supported by the key macroeconomic and demographic data affecting the market
Highlights
* Detailed information is included on market size, measured by both value and volume
* Market shares are covered by manufacturer and/or brand
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Market Definition - The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indigestion preparations, medicated skin products, traditional medicines, vitamins and minerals and other OTC healthcare products at retail selling price (RSP) and includes any applicable taxes. The data in this industry profile is based on the most recent figures available at the time of publication and any currency conversions used in the creation of this report have been calculated using constant 2005 annual average exchange rates.
For the purposes of this report, Asia-Pacific is deemed to consist of Australia, China, India, Japan, Singapore, South Korea and Taiwan.
|
|
TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Market Share 12
CHAPTER 6 Competitive Landscape 13
CHAPTER 7 Leading Companies 14
7.1 GlaxoSmithKline Plc 14
7.2 Pfizer Inc 14
7.3 Wyeth 14
CHAPTER 8 Distribution 16
CHAPTER 9 Market Forecasts 17
9.1 Market Value Forecast 17
CHAPTER 10 Macroeconomic Indicators 18
CHAPTER 11 Further Reading 19
11.1 Sources 19
11.2 Related Datamonitor Research 19
LIST OF TABLES
Table 1: Australia OTC Pharmaceuticals Market Value: $ billion, 2002-2006 9
Table 2: Australia OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 10
Table 3: Australia OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 11
Table 4: Australia OTC Pharmaceuticals Market Share: % Share, by Value, 2004 12
Table 5: Australia OTC Pharmaceuticals Distribution: % Share, by Value, 2004 16
Table 6: Australia OTC Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 17
Table 7: Australia Size of Population (million) , 2002-2006 18
Table 8: Australia GDP (1995=100), 2002-2006 18
Table 9: Australia Exchange Rate, 2002 18
|
|
|
PPLSEN
|
|
|
|
|
